Literature DB >> 12937

Mitochondrial isocitrate dehydrogenase and isocitrate oxidation of rat ventral prostate.

L C Costello, R Franklin, R Stacey.   

Abstract

Mitochondrial preparations isolated from rat ventral prostate were capable of oxidizing isocitrate by way of NADP isocitrate dehydrogenase (NADP-IDH) and NAD-IDH. NAD-IDH activity required ADP for activation. The pH responses for NAD-IDH and NADP-IDH were quite different. The results indicated that two different enzymes were involved in the NAD- and NADP-IDH activities. Indirect evidence indicated that NADPH-NAD transhydrogenase activity might also be involved in the mitochondrial pathway for isocitrate oxidation. NADP-IDH activity was significantly greater than NAD-IDH activity. The oxidation of isocitrate through IDH activity was coupled to the cytochrome system by NADPH- and NADH-cytochrome c reductase activities. Citrate, via isocitrate, oxidation proceeded at a much slower rate suggesting that aconitase activity could be limiting in the oxidation of citrate. In comparison to other tissues, the prostate oxidative enzyme activities are considerably lower. The results suggest that the accumulation of high prostate citrate levels is not due to a limitation imposed by a lack of IDH activity in prostate mitochondria.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 12937     DOI: 10.1159/000458902

Source DB:  PubMed          Journal:  Enzyme        ISSN: 0013-9432


  7 in total

Review 1.  Zinc and zinc transporters in normal prostate and the pathogenesis of prostate cancer.

Authors:  Renty B Franklin; Beatrice Milon; Pei Feng; Leslie C Costello
Journal:  Front Biosci       Date:  2005-09-01

Review 2.  Mitochondrial function, zinc, and intermediary metabolism relationships in normal prostate and prostate cancer.

Authors:  L C Costello; R B Franklin; Pei Feng
Journal:  Mitochondrion       Date:  2005-06       Impact factor: 4.160

Review 3.  A comprehensive review of the role of zinc in normal prostate function and metabolism; and its implications in prostate cancer.

Authors:  Leslie C Costello; Renty B Franklin
Journal:  Arch Biochem Biophys       Date:  2016-04-27       Impact factor: 4.013

Review 4.  Zinc as an anti-tumor agent in prostate cancer and in other cancers.

Authors:  Renty B Franklin; Leslie C Costello
Journal:  Arch Biochem Biophys       Date:  2007-03-16       Impact factor: 4.013

5.  Regulation of citrate metabolism by androgen in the LNCaP human prostate carcinoma cell line.

Authors:  R B Franklin; H H Juang; J Zou; L C Costello
Journal:  Endocrine       Date:  1995-08       Impact factor: 3.633

Review 6.  Cellular mechanisms of zinc dysregulation: a perspective on zinc homeostasis as an etiological factor in the development and progression of breast cancer.

Authors:  Samina Alam; Shannon L Kelleher
Journal:  Nutrients       Date:  2012-07-30       Impact factor: 5.717

7.  Mitochondrial aconitase and citrate metabolism in malignant and nonmalignant human prostate tissues.

Authors:  Keshav K Singh; Mohamed M Desouki; Renty B Franklin; Leslie C Costello
Journal:  Mol Cancer       Date:  2006-04-04       Impact factor: 27.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.